Working memory neural correlates after ketamine in treatment-resistant depression: a randomized placebo-controlled functional magnetic resonance imaging study.

Authors

Adam Fijtman, Níall Lally, Jennifer Evans, Gregory H Jones, Jonathan P Roiser, Carlos A Zarate

Published in

Psychiatry research. Neuroimaging. Volume 365. Pages 112367. Nov 03, 2026. Epub Nov 03, 2026.

Abstract

Ketamine exerts rapid antidepressant effects in treatment-resistant depression (TRD), but its impact on working memory and neural circuitry remains unclear. This secondary analysis investigated behavioral and neural changes during a working memory task post-ketamine infusion in TRD participants versus healthy volunteers (HVs). Data were previously collected from a randomized, double-blind, placebo-controlled, crossover trial of 22 unmedicated TRD participants (14F/8 M) and 19 matched HVs (12F/7 M). Participants received ketamine (0.5mg/kg) and placebo two weeks apart. 3T fMRI was acquired during an N-back task at baseline and two days post-ketamine. Accuracy, reaction time, and differential neural activation during 3-back versus 1-back contrasts were analyzed. Ketamine significantly reduced Montgomery-Asberg Depression Rating Scale scores compared to placebo (p < 0.01). N-back task performance did not significantly differ between drug conditions. In region of interest (ROI) analyses, TRD participants showed reduced activation in the superior temporal gyrus versus HVs (p < 0.01) after both infusions, and both groups demonstrated decreased parieto-occipital junction activation post-ketamine versus post-placebo (p = 0.01). Baseline dorsolateral prefrontal cortex activity significantly predicted post-infusion activity (p < 0.01). Ketamine's antidepressant effects occurred without significant changes in working memory performance, though region-specific task-related brain changes were observed. Interpretation is limited by modest sample size and the exploratory nature of the ROI analyses. CLINICAL TRIAL REGISTRATION: www.clinicaltrials.gov, NCT00088699.

PMID:
42998544
Bibliographic data and abstract were imported from PubMed on 08 Nov 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.